AMANDA PARTON: Open Payments
NPI 1245476183 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,550 in 54 payments from 11 companies in 2025. Trend: 2023 $938 · 2024 $1,675 · 2025 $2,550
Food & beverage: $1,473Travel & lodging: $1,077
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 16 | $1,526 |
| E.R. Squibb & Sons, L.L.C. | 21 | $290 |
| Endologix LLC | 2 | $173 |
| Medtronic, Inc. | 1 | $158 |
| Boston Scientific Corporation | 2 | $141 |
| Novo Nordisk Inc | 3 | $82 |
| PFIZER INC. | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $32 |
| Corcept Therapeutics | 1 | $23 |
Products named: CARDIOMEMS, ENDOCROSS Device, ENDURANT IIS, ENROUTE Transcarotid Neuroprotection System, ELIQUIS, ESPRIT, XACT, Wegovy.
Industry payments across OK — which companies pay providers there.
